Literature DB >> 2908129

The cell biology of mosquito vitellogenesis.

A S Raikhel1.   

Abstract

Insect vitellogenesis involves coordinated activities of the fat body and oocytes. We have studied these activities at the cellular level in the mosquito. During each vitellogenic cycle, the fat body undergoes three successive stages: 1) proliferation of biosynthetic organelles, 2) vitellogenin synthesis, 3) termination of vitellogenin synthesis and degradation of biosynthetic organelles by lysosomes. Analysis with monoclonal antibodies and radiolabelling demonstrated that the mosquito yolk protein consists of two subunits (200-kDa and 65-kDa). Both subunits are glycosylated, their carbohydrate moieties are composed of high-mannose oligosaccharides. The yolk protein subunits are derived from a single 220 kDa precursor detected by an in vitro translation. Oocytes become competent to internalize proteins as a result of juvenile hormone-mediated biogenesis of endocytotic organelles. The yolk protein is then accumulated by receptor-mediated endocytosis. A pathway of the yold protein and factors determining its routing in the oocyte have been studied.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2908129     DOI: 10.1590/s0074-02761987000700019

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  3 in total

1.  Vitellogenin gene expression in autogenous Culex tarsalis.

Authors:  K N Provost-Javier; S Chen; J L Rasgon
Journal:  Insect Mol Biol       Date:  2010-04-27       Impact factor: 3.585

2.  A novel protein produced by the vitellogenic fat body and accumulated in mosquito oocytes.

Authors:  Alan R Hays; Alexander S Raikhel
Journal:  Rouxs Arch Dev Biol       Date:  1990-10

3.  A transcriptome analysis of the Aedes aegypti vitellogenic fat body.

Authors:  Fabiana M Feitosa; Eric Calvo; Emilio F Merino; Alan M Durham; Anthony A James; Antonio G de Bianchi; Osvaldo Marinotti; Margareth L Capurro
Journal:  J Insect Sci       Date:  2006       Impact factor: 1.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.